AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18464745 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan monotherapy for 12 weeks
Number of subjects: 42
Study 18464745 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan in homozygous AT1R 5245 T allele patients
Number of subjects: 42
Study 16848888 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care programme
Number of subjects: 0
Study 16848888 — intervention group
Group type: COMPARATOR
Intervention: Usual care (GP care)
Number of subjects: 0
Study 12946228 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Pap test and HPV testing
Number of subjects: 257
Study 12946228 — intervention group
Group type: COMPARATOR
Intervention: Pap test alone
Number of subjects: 257
Study 10459028 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic removal of tamoxifen‐associated endometrial polyps with concomitant endometrial resection (10 women)
Number of subjects: 20
Study 10459028 — intervention group
Group type: COMPARATOR
Intervention: No concomitant endometrial resection (Control group, 10 women)
Number of subjects: 20
Study 8666137 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP571 (5 mg/kg)
Number of subjects: 21
Study 8666137 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 21
Study 2052335 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgam
Number of subjects: 105
Study 2052335 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer cement
Number of subjects: 105
Study 6190466 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hetastarch (HES)
Number of subjects: 32
Study 6190466 — intervention group
Group type: COMPARATOR
Intervention: 5% plasma protein fraction (PPF)
Number of subjects: 32
Study 31521683 — intervention group
Group type: EXPERIMENTAL
Intervention: Carillon device
Number of subjects: 120
Study 31521683 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 120
Study 29360778 — intervention group
Group type: EXPERIMENTAL
Intervention: P280 (70 g whey protein, 280 kcal)
Number of subjects: 13
Study 29360778 — intervention group
Group type: EXPERIMENTAL
Intervention: M280 (14 g protein, 28 g carbohydrate, 12.4 g fat, 280 kcal)
Number of subjects: 13
Study 29360778 — intervention group
Group type: EXPERIMENTAL
Intervention: M504 (70 g protein, 28 g carbohydrate, 12.4 g fat, 504 kcal)
Number of subjects: 13
Study 29360778 — intervention group
Group type: COMPARATOR
Intervention: Control (2 kcal)
Number of subjects: 13
Study 26796870 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel spacer (HS)
Number of subjects: 20
Study 24158782 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic orthosis (group A "Innovator X")
Number of subjects: 26
Study 24158782 — intervention group
Group type: COMPARATOR
Intervention: Plaster splint (group B)
Number of subjects: 26
Study 23095791 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐CHOP (CHOP plus amifostine)
Number of subjects: 34
Study 23095791 — intervention group
Group type: COMPARATOR
Intervention: CHOP (classical CHOP)
Number of subjects: 34
Study 23095791 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐CHOP
Number of subjects: 34
Study 23095791 — intervention group
Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 34
Study 20128031 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 30
Study 20128031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 17344251 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 31
Study 17344251 — intervention group
Group type: COMPARATOR
Intervention: ST
Number of subjects: 31
Study 16632108 — intervention group
Group type: EXPERIMENTAL
Intervention: VDV3 vaccine
Number of subjects: 0
Study 12791632 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (25 mg Zn daily during the second half of pregnancy)
Number of subjects: 355
Study 12791632 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 355
Study 10561270 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive consolidation chemotherapy (CC)
Number of subjects: 25
Study 10561270 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone marrow transplantation (ABMT)
Number of subjects: 25
Study 10561270 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation (allo BMT)
Number of subjects: 25
Study 8565760 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulglycotide 400 mg three times a day for one year
Number of subjects: 10
Study 8565760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8565760 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulglycotide
Number of subjects: 10
Study 2007672 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical metronidazole (1% cream), applied twice daily
Number of subjects: 108
Study 2007672 — intervention group
Group type: COMPARATOR
Intervention: Oral tetracycline (250 mg, taken twice daily)
Number of subjects: 108
Study 6350473 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg acyclovir intravenously three times daily for five days
Number of subjects: 40
Study 6350473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 29105802 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation combined with cixutumumab
Number of subjects: 50
Study 29105802 — intervention group
Group type: COMPARATOR
Intervention: Androgen deprivation alone
Number of subjects: 50
Study 29105802 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of 365 miRNAs
Number of subjects: 50
Study 28870163 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal LMA
Number of subjects: 0
Study 28870163 — intervention group
Group type: COMPARATOR
Intervention: Supreme LMA
Number of subjects: 0
Study 26595206 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous resistance training for 10 weeks
Number of subjects: 60
Study 26595206 — intervention group
Group type: COMPARATOR
Intervention: Retraining resistance training (5 weeks training, 2 weeks detraining, 5 weeks training)
Number of subjects: 60
Study 24277404 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunal interposition
Number of subjects: 123
Study 24277404 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal with the posterior of residual-stomach
Number of subjects: 123
Study 24277404 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y esophagojejunostomy
Number of subjects: 123
Study 24277404 — intervention group
Group type: COMPARATOR
Intervention: All methods
Number of subjects: 123
Study 20622200 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecarfarin (50 mg)
Number of subjects: 20
Study 20622200 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (17.5 mg)
Number of subjects: 20
Study 19106861 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel preparation
Number of subjects: 5000
Study 19106861 — intervention group
Group type: COMPARATOR
Intervention: No bowel preparation
Number of subjects: 5000
Study 16595163 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine treatment for 4 weeks
Number of subjects: 20
Study 16595163 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (age- and sex-matched)
Number of subjects: 20
Study 16595163 — intervention group
Group type: COMPARATOR
Intervention: Genotyping of three SNP markers
Number of subjects: 20
Study 12928713 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 0.2 mg IT in addition to hyperbaric bupivacaine 10 mg IT
Number of subjects: 45
Study 12928713 — intervention group
Group type: COMPARATOR
Intervention: hyperbaric bupivacaine 10 mg IT
Number of subjects: 45
Study 11754675 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 microgram total dose, 2 puffs in each nostril once daily for 21 days)
Number of subjects: 95
Study 11754675 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray (2 puffs in each nostril once daily for 21 days)
Number of subjects: 95
Study 11754675 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 95
Study 11754675 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 95
Study 9481097 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (1.5 mg/kg/day) with prednisolone (2 mg/kg on alternate days)
Number of subjects: 29
Study 9481097 — intervention group
Group type: COMPARATOR
Intervention: Pulse intravenous cyclophosphamide (500 mg/m2 body surface area monthly) with prednisolone (2 mg/kg on alternate days)
Number of subjects: 29
Study 8320445 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical neck dissection
Number of subjects: 104
Study 8320445 — intervention group
Group type: COMPARATOR
Intervention: Conservative neck dissection
Number of subjects: 104
Study 3743615 — intervention group
Group type: EXPERIMENTAL
Intervention: oxprenolol Oros, 16/260 mg/day
Number of subjects: 9
Study 3743615 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol, 100 mg/day
Number of subjects: 9
Study 3743615 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study 28651844 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivacaftor
Number of subjects: 161
Study 28651844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study 26709241 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (21 g/day for 8 weeks)
Number of subjects: 39
Study 26709241 — intervention group
Group type: COMPARATOR
Intervention: Placebo (iso-nitrogenous)
Number of subjects: 39
Study 24709430 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised toothbrushing with 1,400 ppm/31 percent fluoride xylitol toothpaste
Number of subjects: 196
Study 24709430 — intervention group
Group type: COMPARATOR
Intervention: Supervised toothbrushing with 1,450 ppm fluoride sorbitol toothpaste
Number of subjects: 196
Study 24169071 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive exercises rehabilitation
Number of subjects: 16
Study 24169071 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-injured subjects)
Number of subjects: 16
Study 21145054 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-balloon colonoscopy (SBC)
Number of subjects: 30
Study 21145054 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy (SC)
Number of subjects: 30
Study 21145054 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover to SBC after SC failure
Number of subjects: 30
Study 21145054 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 19052124 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril plus amlodipine
Number of subjects: 11506
Study 19052124 — intervention group
Group type: COMPARATOR
Intervention: Benazepril plus hydrochlorothiazide
Number of subjects: 11506
Study 16365068 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignan complex (500 mg/d of SDG)
Number of subjects: 22
Study 16365068 — intervention group
Group type: COMPARATOR
Intervention: Placebo (low-fat muffin without lignan complex)
Number of subjects: 22
Study 14682107 — intervention group
Group type: EXPERIMENTAL
Intervention: Postexcisional radiation therapy
Number of subjects: 0
Study 14682107 — intervention group
Group type: COMPARATOR
Intervention: No radiation therapy (excision alone)
Number of subjects: 0
Study 10827148 — intervention group
Group type: EXPERIMENTAL
Intervention: PR + IM
Number of subjects: 95
Study 10827148 — intervention group
Group type: COMPARATOR
Intervention: PR
Number of subjects: 95
Study 8981490 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12 (methylcobalamin; 0.5 mg/day intravenously for 11 days, followed by 2 mg x 3/day orally for 7 days)
Number of subjects: 8
Study 8981490 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 8
Study 1294918 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (2 micrograms/kg)
Number of subjects: 28
Study 1294918 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 28
Study 3921146 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural psychotherapy from a nurse therapist
Number of subjects: 0
Study 3921146 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment from a general practitioner
Number of subjects: 0
Study 3921146 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover behavioural treatment from the nurse
Number of subjects: 0
Study 3921146 — intervention group
Group type: EXPERIMENTAL
Intervention: Dropped out or refused therapy
Number of subjects: 0
Study 31672711 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of a progestogen-only pill (POP, desogestrel) plus rapid access to a local sexual and reproductive health (SRH) clinic.
Number of subjects: 626
Study 31672711 — intervention group
Group type: COMPARATOR
Intervention: Provision of emergency contraception (levonorgestrel) alone (standard care).
Number of subjects: 626
Study 30424728 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Bifidobacterium longum subsp. infantis BB‐02, Streptococcus thermophilus TH‐4, Bifidobacterium animalis subsp. lactis BB‐12)
Number of subjects: 1099
Study 30424728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1099
Study 27568318 — intervention group
Group type: EXPERIMENTAL
Intervention: Position change after angiography
Number of subjects: 60
Study 27568318 — intervention group
Group type: COMPARATOR
Intervention: Supine position with complete bed rest (Control)
Number of subjects: 60
Study 25462029 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified mindfulness-based stress reduction (MBSR) intervention
Number of subjects: 53
Study 25462029 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral stress-eating intervention (SEI)
Number of subjects: 53
Study 25462029 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (MBSR + SEI)
Number of subjects: 53
Study 22531334 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation
Number of subjects: 30
Study 22531334 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 30
Study 22531334 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous breathing
Number of subjects: 30
Study 22531334 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 30
Study 20519067 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 28
Study 18598851 — intervention group
Group type: EXPERIMENTAL
Intervention: Single training session followed by sleep
Number of subjects: 2
Study 18598851 — intervention group
Group type: COMPARATOR
Intervention: Two rotation adaptation training sessions
Number of subjects: 2
Study 16442958 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report group
Number of subjects: 34
Study 16442958 — intervention group
Group type: COMPARATOR
Intervention: Shadow group
Number of subjects: 34
Study 14647028 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal mupirocin
Number of subjects: 0
Study 14647028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11146310 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol therapy as a single weekly dose of 0.08 microg/kg b.w. (Group A)
Number of subjects: 30
Study 11146310 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol therapy divided into two equal doses (Group B)
Number of subjects: 30
Study 11146310 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol therapy divided into three doses (Group C)
Number of subjects: 30
Study 11146310 — intervention group
Group type: COMPARATOR
Intervention: Comparison of PTH % variation among the three groups
Number of subjects: 30
Study 8772602 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (T)
Number of subjects: 12
Study 8772602 — intervention group
Group type: COMPARATOR
Intervention: 5 alpha-dihydrotestosterone
Number of subjects: 12
Study 1531069 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol 1 (rest/exercise)
Number of subjects: 11
Study 1531069 — intervention group
Group type: COMPARATOR
Intervention: Protocol 2 (exercise/rest)
Number of subjects: 11
Study 6382197 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoactive intestinal peptide (V.I.P.) intravenously at 6 pmol kg‐1 min‐1 for 15 minutes
Number of subjects: 7
Study 6382197 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoactive intestinal peptide (V.I.P.)
Number of subjects: 7
Study 6382197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 31684932 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory learning and action (PLA) intervention
Number of subjects: 0
Study 28043751 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicate‐substituted calcium phosphate (Si‐CaP) as a bone graft substitute
Number of subjects: 40
Study 28043751 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone from the iliac crest
Number of subjects: 40
Study 28043751 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicate‐substituted calcium phosphate (Si‐CaP)
Number of subjects: 40
Study 28043751 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone
Number of subjects: 40
Study 26691646 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiosk-based interactive patient education intervention
Number of subjects: 200
Study 26691646 — intervention group
Group type: COMPARATOR
Intervention: Attention-control
Number of subjects: 200
Study 24251428 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser lithotripsy
Number of subjects: 60
Study 24251428 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic lithotripsy
Number of subjects: 60
Study 21531124 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide/formoterol pMDI 320/9μg
Number of subjects: 0
Study 21531124 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide/formoterol pMDI 160/9μg
Number of subjects: 0
Study 21531124 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol dry powder inhaler (DPI) 9μg
Number of subjects: 0
Study 21531124 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide/formoterol pMDI
Number of subjects: 0
Study 21531124 — intervention group
Group type: COMPARATOR
Intervention: formoterol
Number of subjects: 0
Study 18623907 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningitis B vaccine (two doses)
Number of subjects: 171800
Study 18623907 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 171800
Study 17031257 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention, details not specified
Number of subjects: 0
Study 17031257 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 0
Study 14572890 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg isosorbide mononitrate, given intravaginally 12 h before induction
Number of subjects: 100
Study 14572890 — intervention group
Group type: COMPARATOR
Intervention: Placebo, given intravaginally 12 h before induction
Number of subjects: 100
Study 10639021 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg DHEA
Number of subjects: 23
Study 10639021 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg DHEA
Number of subjects: 23
Study 10639021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 8606314 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone administration of SF-36
Number of subjects: 172
Study 8606314 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face administration of SF-36
Number of subjects: 172
Study 8606314 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administration of SF-36
Number of subjects: 172
Study 1417339 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect endolymphatic therapy with bicillin‐3
Number of subjects: 137
Study 1417339 — intervention group
Group type: COMPARATOR
Intervention: Routine penicillin therapy
Number of subjects: 137
Study 6198058 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycin
Number of subjects: 39
Study 6198058 — intervention group
Group type: COMPARATOR
Intervention: Quadruple chemotherapy
Number of subjects: 39
Study 6198058 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum alpha-fetoprotein levels
Number of subjects: 39
Study 29953575 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline-hydroxyethyl starch (HS-HES) solution
Number of subjects: 50
Study 29953575 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 50
Study 27673385 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine (0.1 to 0.2 to 0.3 μg/kg/min)
Number of subjects: 60
Study 27673385 — intervention group
Group type: COMPARATOR
Intervention: Dopamine (10 to 15 to 20 μg/kg/min)
Number of subjects: 60
Study 27673385 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 60
Study 27673385 — intervention group
Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 60
Study 25670057 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimax™ bioactive stent (BAS)
Number of subjects: 1800
Study 25670057 — intervention group
Group type: COMPARATOR
Intervention: Synergy™ drug-eluting stent (EES)
Number of subjects: 1800
Study 23766396 — intervention group
Group type: EXPERIMENTAL
Intervention: Alberta Infant Motor Scale (AIMS)
Number of subjects: 116
Study 23766396 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychomotor Developmental Index (PDI) of the Bayley Scales of Infant Development‐Dutch Second Edition (BSID‐II‐NL)
Number of subjects: 116
Study 21044314 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month physical activity stimulation program (lifestyle intervention and fitness training)
Number of subjects: 50
Study 21044314 — intervention group
Group type: COMPARATOR
Intervention: Regular pediatric physiotherapy (control group)
Number of subjects: 50
Study 18362876 — intervention group
Group type: EXPERIMENTAL
Intervention: Print advertising for bipolar disorder study
Number of subjects: 526
Study 17001402 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed educational information
Number of subjects: 75
Study 17001402 — intervention group
Group type: COMPARATOR
Intervention: Basic information about the procedure
Number of subjects: 75
Study 12437707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine
Number of subjects: 36
Study 12437707 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intrathecal morphine)
Number of subjects: 36
Study 10357168 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored behavioural programme with telephone support from the therapist
Number of subjects: 30